| scholarly article | Q13442814 |
| P2093 | author name string | Ahmed Tawakol | |
| Amr Abdelbaky | |||
| P2860 | cites work | The molecular mechanisms of the thrombotic complications of atherosclerosis | Q24656816 |
| Novel clinical markers of vascular wall inflammation | Q28190821 | ||
| C-reactive protein and other inflammatory risk markers in acute coronary syndromes | Q28195425 | ||
| Inflammation in atherosclerosis | Q29547428 | ||
| Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus | Q33691309 | ||
| Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. | Q34132798 | ||
| Inflammatory bio-markers and cardiovascular risk prediction | Q34941391 | ||
| Multiple mechanisms of thrombosis complicating atherosclerotic plaques. | Q52541865 | ||
| Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. | Q53514180 | ||
| Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. | Q54301756 | ||
| Granulocytes utilize different energy sources for movement and phagocytosis | Q71624471 | ||
| Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake | Q72681602 | ||
| Coronary risk factors and plaque morphology in men with coronary disease who died suddenly | Q73254792 | ||
| Evidence of hypoxic areas within the arterial wall in vivo | Q77297609 | ||
| CARDIAC METABOLISM | Q78295863 | ||
| In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients | Q79328884 | ||
| The biochemical basis of phagocytosis. IV. Some aspects of carbohydrate metabolism during phagocytosis | Q79383786 | ||
| Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5 | Q80216867 | ||
| New opportunities for identification and reduction of coronary risk: treatment of vulnerable patients, arteries, and plaques | Q83187653 | ||
| Detection of inflamed atherosclerotic lesions with diadenosine-5',5'''-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography | Q35080574 | ||
| Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study | Q35303221 | ||
| Motion-frozen myocardial perfusion SPECT improves detection of coronary artery disease in obese patients | Q36366744 | ||
| Mast cells and degradation of pericellular and extracellular matrices: potential contributions to erosion, rupture and intraplaque haemorrhage of atherosclerotic plaques | Q36979408 | ||
| Imaging of atherosclerotic cardiovascular disease | Q37089743 | ||
| Retrospective study of coronary uptake of 18F-fluorodeoxyglucose in association with calcification and coronary artery disease: a preliminary study | Q37399878 | ||
| Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis | Q37421663 | ||
| FDG-PET imaging of atherosclerosis: Do we know what we see? | Q37702572 | ||
| Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? | Q37761792 | ||
| Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET. | Q38713992 | ||
| Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1. | Q39784266 | ||
| 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease | Q39946694 | ||
| Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations | Q40091380 | ||
| Coronary Plaque Disruption | Q40459835 | ||
| Uptake of 11C-choline in mouse atherosclerotic plaques | Q43097946 | ||
| Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina | Q43098198 | ||
| Gene expression and 18FDG uptake in atherosclerotic carotid plaques | Q43166669 | ||
| Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography | Q43198454 | ||
| Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice | Q43266220 | ||
| FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis. | Q43270438 | ||
| F-18 FDG uptake in the large arteries: a new observation | Q43567300 | ||
| Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro | Q44293156 | ||
| Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography | Q44366483 | ||
| Intraplaque hemorrhage and progression of coronary atheroma | Q44688413 | ||
| Imaging the vulnerable plaque: a scintillating light at the end of the tunnel? | Q44964606 | ||
| (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study | Q44964637 | ||
| Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. | Q45191226 | ||
| Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. | Q46011418 | ||
| Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation | Q46086909 | ||
| Imaging of early inflammation in low-to-moderate carotid stenosis by 18-FDG-PET. | Q46094385 | ||
| Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification | Q46138309 | ||
| Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET). | Q46181310 | ||
| Fusion of positron emission tomography and coronary computed tomographic angiography identifies fluorine 18 fluorodeoxyglucose uptake in the left main coronary artery soft plaque | Q46264613 | ||
| In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis | Q46268489 | ||
| Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods. | Q46312454 | ||
| Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice | Q46365485 | ||
| Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction | Q46480043 | ||
| Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography | Q46535642 | ||
| Association of vascular 18F-FDG uptake with vascular calcification. | Q46639228 | ||
| Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography | Q46662614 | ||
| The paradox of hypoxic and oxidative stress in atherosclerosis | Q46678594 | ||
| 18F-choline images murine atherosclerotic plaques ex vivo | Q46853333 | ||
| ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo | Q46888991 | ||
| FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries | Q46934623 | ||
| Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants | Q48296662 | ||
| (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. | Q48904408 | ||
| P433 | issue | 1 | |
| P921 | main subject | inflammation | Q101991 |
| positron emission tomography | Q208376 | ||
| P304 | page(s) | 41-49 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Current cardiovascular imaging reports | Q26853805 |
| P1476 | title | Noninvasive Positron Emission Tomography Imaging of Coronary Arterial Inflammation | |
| P478 | volume | 4 |
| Q39686243 | Cardiac PET, CT, and MR: what are the advantages of hybrid imaging? |
| Q65000820 | Imaging plaque inflammation in asymptomatic cocaine addicted individuals with simultaneous positron emission tomography/magnetic resonance imaging. |
| Q30474772 | Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification |
Search more.